106 related articles for article (PubMed ID: 10584991)
1. The "point of no return" and the rate of progression in the natural history of IgA nephritis.
Schöll U; Wastl U; Risler T; Braun N; Grabensee B; Heering P; Schollmeyer P; Zäuner I; Stein G; Fünfstück R; Keller F
Clin Nephrol; 1999 Nov; 52(5):285-92. PubMed ID: 10584991
[TBL] [Abstract][Full Text] [Related]
2. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.
Komatsu H; Fujimoto S; Sato Y; Hara S; Yamada K; Morita S; Eto T
J Nephrol; 2005; 18(6):690-5. PubMed ID: 16358226
[TBL] [Abstract][Full Text] [Related]
3. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
Pozzi C; Del Vecchio L; Locatelli F
G Ital Nefrol; 2002; 19(5):523-8. PubMed ID: 12439840
[TBL] [Abstract][Full Text] [Related]
4. The natural history of IgA nephritis in Singapore.
Woo KT; Edmondson RP; Wu AY; Chiang GS; Pwee HS; Lim CH
Clin Nephrol; 1986 Jan; 25(1):15-21. PubMed ID: 3955904
[TBL] [Abstract][Full Text] [Related]
5. Contribution on the correlation between morphometric parameters gained from the renal cortex and renal function in IgA nephritis.
Mackensen-Haen S; Eissele R; Bohle A
Lab Invest; 1988 Aug; 59(2):239-44. PubMed ID: 3404975
[TBL] [Abstract][Full Text] [Related]
6. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
[TBL] [Abstract][Full Text] [Related]
7. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation.
Tang Z; Ji SM; Chen DR; Wen JQ; Chen JS; Liu ZH; Li LS
Ren Fail; 2008; 30(6):611-6. PubMed ID: 18661411
[TBL] [Abstract][Full Text] [Related]
8. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
Siu YP; Leung KT; Tong MK; Kwan TH
Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory markers and the progression of IgA glomerulonephritis.
Kaartinen K; Syrjänen J; Pörsti I; Hurme M; Harmoinen A; Pasternack A; Huhtala H; Mustonen J
Nephrol Dial Transplant; 2008 Apr; 23(4):1285-90. PubMed ID: 17986475
[TBL] [Abstract][Full Text] [Related]
10. [Acute reversible kidney failure in IgA nephritis].
Lettgen B; Rascher W
Klin Padiatr; 1991; 203(2):124-8. PubMed ID: 2033905
[TBL] [Abstract][Full Text] [Related]
11. Comparison of pathological lesions on repeated renal biopsies in 73 patients with primary IgA glomerulonephritis: value of quantitative scoring and approach to final prognosis.
Alamartine E; Sabatier JC; Berthoux FC
Clin Nephrol; 1990 Aug; 34(2):45-51. PubMed ID: 2225552
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in immunoglobulin-A nephropathy.
Muthukumar T; Fernando ME; Jayakumar M
J Assoc Physicians India; 2002 Nov; 50():1354-9. PubMed ID: 12583461
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the clinical and laboratory features of thin basement membrane disease (TBMD) and IgA glomerulonephritis (IgA GN).
Auwardt R; Savige J; Wilson D
Clin Nephrol; 1999 Jul; 52(1):1-4. PubMed ID: 10442488
[TBL] [Abstract][Full Text] [Related]
14. Impact of interferon-gamma and interleukin-4 gene polymorphisms on development and progression of IgA nephropathy in Japanese patients.
Masutani K; Miyake K; Nakashima H; Hirano T; Kubo M; Hirakawa M; Tsuruya K; Fukuda K; Kanai H; Otsuka T; Hirakata H; Iida M
Am J Kidney Dis; 2003 Feb; 41(2):371-9. PubMed ID: 12552499
[TBL] [Abstract][Full Text] [Related]
15. [The course and prognosis of mesangioproliferative glomerulonephritis].
Shilov EM; Tareeva IE; Ivanov AA; Troepol'skaia OV; Krasnova TN; Varshavskiĭ VA; Proskurneva EP; Ivanova LV; Khudova IIu; Miroshnichenko NG
Ter Arkh; 2002; 74(6):11-8. PubMed ID: 12136475
[TBL] [Abstract][Full Text] [Related]
16. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
Manno C; Strippoli GF; D'Altri C; Torres D; Rossini M; Schena FP
Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of factors affecting the course of renal disease progression in patients with established renal insufficiency].
Sato Y; Fujimoto S; Yamada K; Hara S; Eto T
Nihon Jinzo Gakkai Shi; 2003; 45(4):372-7. PubMed ID: 12806974
[TBL] [Abstract][Full Text] [Related]
18. Primary IgA nephropathy: natural history and factors of importance in the progression of renal impairment.
Ibels LS; Gyory AZ; Caterson RJ; Pollock CA; Mahony JF; Waugh DA; Roger SD; Coulshed S
Kidney Int Suppl; 1997 Oct; 61():S67-70. PubMed ID: 9328970
[No Abstract] [Full Text] [Related]
19. Prognostic factors for a composite end-point of renal outcomes in patients with chronic kidney disease.
Morita S; Fukuhara S; Akizawa T; Asano Y; Koshikawa S; Koide K; Kurokawa K
Ther Apher Dial; 2006 Feb; 10(1):72-7. PubMed ID: 16556140
[TBL] [Abstract][Full Text] [Related]
20. Presentation, prognosis and outcome of IgA nephropathy in Indian adults.
Chacko B; John GT; Neelakantan N; Korula A; Balakrishnan N; Kirubakaran MG; Jacob CK
Nephrology (Carlton); 2005 Oct; 10(5):496-503. PubMed ID: 16221102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
